Gut bacteria and organ damage in sepsis
Part of Infections clinical trials.
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are either a patient with sepsis in the ICU, or a healthy volunteer without any chronic diseases.
- You do not have long-term liver, kidney, or bowel disease.
- You are not currently on chemotherapy or radiation for cancer.
- If you are a healthy volunteer, you have not taken antibiotics, probiotics, or had an infection in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This study looks at how the immune system responds in patients who develop sepsis after surgery and how it relates to kidney injury. It aims to help improve care for conditions like this.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at certain markers in the blood to help predict and understand lung injury in people who have sepsis from an infection outside the lungs. By joining, you help doctors learn how to better protect the lungs of future patients with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.